These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29850769)

  • 1. The size matters? A computational tool to design bivalent ligands.
    Pérez-Benito L; Henry A; Matsoukas MT; Lopez L; Pulido D; Royo M; Cordomí A; Tresadern G; Pardo L
    Bioinformatics; 2018 Nov; 34(22):3857-3863. PubMed ID: 29850769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design strategies for bivalent ligands targeting GPCRs.
    Shonberg J; Scammells PJ; Capuano B
    ChemMedChem; 2011 Jun; 6(6):963-74. PubMed ID: 21520422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers.
    Berque-Bestel I; Lezoualc'h F; Jockers R
    Curr Drug Discov Technol; 2008 Dec; 5(4):312-8. PubMed ID: 19075611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules.
    Qian M; Sun Z; Chen X; Van Calenbergh S
    Bioorg Chem; 2023 Nov; 140():106809. PubMed ID: 37651896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of bivalent ligands targeting putative GPCR dimers.
    Huang B; St Onge CM; Ma H; Zhang Y
    Drug Discov Today; 2021 Jan; 26(1):189-199. PubMed ID: 33075471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosite: a method for predicting allosteric sites.
    Huang W; Lu S; Huang Z; Liu X; Mou L; Luo Y; Zhao Y; Liu Y; Chen Z; Hou T; Zhang J
    Bioinformatics; 2013 Sep; 29(18):2357-9. PubMed ID: 23842804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
    Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
    Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
    Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP
    J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of G protein-coupled receptors.
    May LT; Leach K; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors.
    Valant C; Robert Lane J; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2012; 52():153-78. PubMed ID: 21910627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
    Fernandes SM; Lee YS; Gillies RJ; Hruby VJ
    Bioorg Med Chem; 2014 Nov; 22(22):6360-5. PubMed ID: 25438759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity.
    Antony J; Kellershohn K; Mohr-Andrä M; Kebig A; Prilla S; Muth M; Heller E; Disingrini T; Dallanoce C; Bertoni S; Schrobang J; Tränkle C; Kostenis E; Christopoulos A; Höltje HD; Barocelli E; De Amici M; Holzgrabe U; Mohr K
    FASEB J; 2009 Feb; 23(2):442-50. PubMed ID: 18842964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach.
    Hovah ME; Holzgrabe U
    Med Res Rev; 2024 May; ():. PubMed ID: 38751227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivity.
    Schmitz J; van der Mey D; Bermudez M; Klöckner J; Schrage R; Kostenis E; Tränkle C; Wolber G; Mohr K; Holzgrabe U
    J Med Chem; 2014 Aug; 57(15):6739-50. PubMed ID: 25051097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloscore: a method for predicting allosteric ligand-protein interactions.
    Li S; Shen Q; Su M; Liu X; Lu S; Chen Z; Wang R; Zhang J
    Bioinformatics; 2016 May; 32(10):1574-6. PubMed ID: 26803160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors.
    Salama I; Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3753-6. PubMed ID: 25047579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.